| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/08/2023 | 13:00 | InvestorsHub NewsWire | Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv | TSXV:MPH | Medicure Inc |
| 01/02/2023 | 13:00 | PR Newswire (Canada) | MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS | TSXV:MPH | Medicure Inc |
| 24/11/2022 | 23:00 | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022 | TSXV:MPH | Medicure Inc |
| 17/11/2022 | 23:00 | PR Newswire (Canada) | MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022 | TSXV:MPH | Medicure Inc |
| 26/09/2022 | 15:00 | PR Newswire (Canada) | EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC. | TSXV:MPH | Medicure Inc |
| 24/08/2022 | 23:00 | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022 | TSXV:MPH | Medicure Inc |
| 17/08/2022 | 23:00 | PR Newswire (Canada) | MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022 | TSXV:MPH | Medicure Inc |
| 20/06/2022 | 23:00 | PR Newswire (Canada) | MEDICURE ANNOUNCES RESULTS OF 2022 AGM | TSXV:MPH | Medicure Inc |
| 31/05/2022 | 01:00 | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICER | TSXV:MPH | Medicure Inc |
| 28/04/2022 | 02:00 | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021 | TSXV:MPH | Medicure Inc |
| 26/04/2022 | 19:00 | PR Newswire (Canada) | MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST | TSXV:MPH | Medicure Inc |
| 23/03/2022 | 22:00 | PR Newswire (Canada) | MEDICURE ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SUCCESSION PLAN | TSXV:MPH | Medicure Inc |
| 22/02/2022 | 15:00 | PR Newswire (Canada) | Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy | TSXV:MPH | Medicure Inc |
| 09/02/2022 | 15:53 | PR Newswire (Canada) | Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy | TSXV:MPH | Medicure Inc |
| 22/11/2021 | 23:00 | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter Ended September 30, 2021 | TSXV:MPH | Medicure Inc |
| 22/11/2021 | 15:00 | PR Newswire (Canada) | Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans | TSXV:MPH | Medicure Inc |
| 04/11/2021 | 22:00 | PR Newswire (Canada) | Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint | TSXV:MPH | Medicure Inc |
| 27/08/2021 | 23:00 | PR Newswire (Canada) | Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021 | TSXV:MPH | Medicure Inc |
| 30/07/2021 | 14:00 | PR Newswire (Canada) | Medicure Announces Grant of Stock Options | TSXV:MPH | Medicure Inc |
| 24/06/2021 | 23:01 | PR Newswire (Canada) | Medicure Announces Appointment of David Gurvey as Chief Financial Officer | TSXV:MPH | Medicure Inc |
| 10/05/2021 | 23:30 | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter Ended March 31, 2021 | TSXV:MPH | Medicure Inc |
| 05/05/2021 | 21:03 | PR Newswire (Canada) | Medicure 2020 Annual and Q1 2021 Results and Conference Call Date | TSXV:MPH | Medicure Inc |
| 28/04/2021 | 23:01 | PR Newswire (Canada) | Medicure Announces Resignation of Chief Financial Officer and Succession Plan | TSXV:MPH | Medicure Inc |
| 21/04/2021 | 00:00 | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020 | TSXV:MPH | Medicure Inc |
| 30/03/2021 | 01:26 | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021 | TSXV:MPH | Medicure Inc |
| 08/03/2021 | 23:30 | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021 | TSXV:MPH | Medicure Inc |
| 23/02/2021 | 00:17 | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021 | TSXV:MPH | Medicure Inc |
| 04/02/2021 | 23:30 | PR Newswire (Canada) | Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021 | TSXV:MPH | Medicure Inc |
| 27/01/2021 | 23:30 | PR Newswire (Canada) | Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofib... | TSXV:MPH | Medicure Inc |
| 07/01/2021 | 23:30 | PR Newswire (Canada) | Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phos... | TSXV:MPH | Medicure Inc |